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Background
Severe sepsis was the subject of intense debate over the
years, and in the last twenty years there has been a con-
stant effort to identify therapies that reduce mortality.
Although the inflammatory response is often adapted to
the etiologic agent and to the increase of the mediators in
association with organ dysfunction, it is not currently
possible to rapidly assess the patients’ ability to develop an
appropriate response.
Methods
We conducted a retrospective study over a period of
7 months, January to July 2013, in which we included
90 patients with primary diagnosis of sepsis, admitted to
the Clinical Hospital of Infectious Diseases “Sf. Para-
scheva”, Iaşi, where we evaluated the following parameters:
clinical, etiological, lab results, Carmeli prognostic score,
APACHE II score, antibiotherapy. We tried to identify
correlations and statistically significant differences. The
data were processed using 16.0. SPSS version.
Results
No statistically significant difference was identified
between the ages of patients who had two or three asso-
ciated organ dysfunction compared to those with
uncomplicated sepsis (p=0.292). Etiologic agents could
be established in only 16 cases, organic response and
systemic affection were varied, and we did not identify
correlations between inflammatory syndrome para-
meters, regardless of the Carmeli or APACHE II prog-
nostic score group, or identification of the etiologic
agent. Antibiotherapy in double association (84 cases)
has decreased the fever and periods of hospitalization,
and we observed no statistically significant difference
compared to the cases in which the triple therapy was
used.
Conclusion
More than two thirds of patients were assigned in group
2 and 3 of Carmeli and APACHE II scores (79 and 74
patients). We identified correlations between the high
values of glucose and the presence of organ dysfunction
in sepsis in studied patients. No statistically significant
difference was found regarding the period of decreasing
fever, of the hospitalization’s duration in patients with
one, two or more organ dysfunctions with or without of
identified etiologic agent. No correlations were observed
between the development of sepsis severity (patients
with APACHE II and III) and the presence of anemia or
thrombocytopenia, or between fever syndrome and
inflammatory syndrome.
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